Trial Outcomes & Findings for Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study (NCT NCT00944216)

Results Overview

Recruitment status

TERMINATED

Study phase

PHASE4

Target enrollment

1 participants

Primary outcome timeframe

12 weeks

Results posted on

2022-02-04

Screening and recruitment occurred in June and July of 2009 in university dermatology clinic.

Participant milestones
Measure	Treatment Salkera foam twice a day
Overall Study STARTED	1
Overall Study COMPLETED	1
Overall Study NOT COMPLETED	0

Withdrawal data not reported

Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study

Baseline characteristics by cohort
Measure	Treatment n=1 Participants Salkera foam twice a day
Age, Categorical <=18 years	0 Participants n=5 Participants
Age, Categorical Between 18 and 65 years	1 Participants n=5 Participants
Age, Categorical >=65 years	0 Participants n=5 Participants
Sex: Female, Male Female	1 Participants n=5 Participants
Sex: Female, Male Male	0 Participants n=5 Participants
Region of Enrollment United States	1 participants n=5 Participants

Timeframe: 12 weeks

Population: This outcome was not assessed.

Outcome data not reported

Timeframe: 12 wks

Population: This outcome was not assessed.

Subject disease severity score: None (0), mild (1), mild/moderate (2), moderate (3), moderate/severe (4), severe (5).

Outcome data not reported

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

Wright State University School of Medicine, Dept of Dermatology

Phone: 927-224-3345